Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, was given the choice to resign or be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback